NASHVILLE, Tenn. – Omnis Health recently announced that Weis Markets has agreed to add its line of Embrace products to their blood glucose monitoring planogram, including the EmbracePRO system, the EmbraceEVO system, and the EmbraceEVO Complete Gestational Diabetes Monitoring Kit.
To combat the recent reduction in competitive bidding, Omnis Health has launched the EmbracePRO into the retail pharmacy chain as a viable solution to the ever-changing reimbursement landscape for diabetes testing, the company noted.